These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 19001815)
21. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies. Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301 [TBL] [Abstract][Full Text] [Related]
23. Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum. Haas M Curr Opin Nephrol Hypertens; 2012 May; 21(3):264-71. PubMed ID: 22388553 [TBL] [Abstract][Full Text] [Related]
24. Detection of plasma cells, C4d deposits and donor-specific antibodies on sequential graft biopsies of renal transplant recipients with chronic dysfunction. Martin L; Charon-Barra C; Bocrie O; Guignier F; D'Athis P; Dautin G; de la Vega MF; Justrabo E; Rifle G; Mousson C Transpl Immunol; 2010 Feb; 22(3-4):110-4. PubMed ID: 19900552 [TBL] [Abstract][Full Text] [Related]
25. Specificity and sensitivity of screening for anti-HLA antibodies in kidney allograft dysfunction. Viana H; Nolasco F; Santos MC; Carvalho F; Galvão MJ; Santos AR; Bordalo J; Dos Santos JR Transplant Proc; 2009 Apr; 41(3):859-61. PubMed ID: 19376372 [TBL] [Abstract][Full Text] [Related]
26. Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients. Boratyńska M; Banasik M; Hałoń A; Patrzałek D; Klinger M Transplant Proc; 2007 Nov; 39(9):2711-4. PubMed ID: 18021965 [TBL] [Abstract][Full Text] [Related]
28. The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies. Yousem SA; Zeevi A Am J Surg Pathol; 2012 Jul; 36(7):987-92. PubMed ID: 22510758 [TBL] [Abstract][Full Text] [Related]
31. Glomerular inflammation in renal allografts biopsies after the first year: cell types and relationship with antibody-mediated rejection and graft outcome. Papadimitriou JC; Drachenberg CB; Munivenkatappa R; Ramos E; Nogueira J; Sailey C; Klassen DK; Haririan A Transplantation; 2010 Dec; 90(12):1478-85. PubMed ID: 21042235 [TBL] [Abstract][Full Text] [Related]
32. Progress in understanding humoral rejection in kidney transplantation: implications for patient management. Pascual MA; Crespo M; Tolkoff-Rubin N Nefrologia; 2001; 21(4):327-31. PubMed ID: 11816504 [TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of antibody-mediated kidney allograft rejection. Böhmig G; Regele H Transpl Int; 2003 Nov; 16(11):773-87. PubMed ID: 14534774 [TBL] [Abstract][Full Text] [Related]
34. Donor-specific antibody detection for diagnosis of antibody-mediated rejection in kidney transplantation. Gautreau C; Suberbielle C; Andrade J; Charron D Clin Transpl; 2006; ():502. PubMed ID: 18365411 [No Abstract] [Full Text] [Related]
35. Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation. Morozumi K; Takeda A; Otsuka Y; Horike K; Gotoh N; Narumi S; Watarai Y; Kobayashi T Nephrology (Carlton); 2016 Jul; 21 Suppl 1():4-8. PubMed ID: 26971899 [TBL] [Abstract][Full Text] [Related]
36. Graft loss associated with late humoral rejection after renal transplantation. Sun Q; Li L Clin Transpl; 2006; ():521-5. PubMed ID: 18365417 [TBL] [Abstract][Full Text] [Related]
37. Significance of peritubular capillary, glomerular, and arteriolar C4d staining patterns in paraffin sections of early kidney transplant biopsies. Kikić Z; Regele H; Nordmeyer V; Wahrmann M; Kletzmayr J; Bartel G; Böhmig GA Transplantation; 2011 Feb; 91(4):440-6. PubMed ID: 21127459 [TBL] [Abstract][Full Text] [Related]
38. Pathology of C4d-negative antibody-mediated rejection in renal allografts. Haas M Curr Opin Organ Transplant; 2013 Jun; 18(3):319-26. PubMed ID: 23283250 [TBL] [Abstract][Full Text] [Related]